This story was originally published July 8
German sequencing service provider GATC Biotech said last week that it will install a second Illumina HiSeq 2000 instrument, which will go into production later this month.
The company purchased its first HiSeq 2000 earlier this year (IS 1/26/2010). Both instruments will be used to sequence pediatric brain tumors for a project that is part of the International Cancer Genome Consortium (IS 5/25/2010), as well as for large population studies and screens for mutations causing rare diseases.
Besides the two HiSeq instruments, GATC is equipped with three Illumina GAs, two 454 GS FLX, and nine ABI 3730xl sequencers. The new HiSeq increases the firm's sequencing capacity to almost 20 terabases per year, the company said.